Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Travera Inc
Brown University
QuantumLeap Healthcare Collaborative
Eastern Cooperative Oncology Group
NKGen Biotech, Inc.
Washington University School of Medicine
M.D. Anderson Cancer Center